Developing new smallpox vaccines.

Rosenthal, S. R.; Merchlinsky, M.; Kleppinger, C.; Goldenthal, K. L.

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Developing new smallpox vaccines.

Published Date:

2001 Nov-Dec

Source:

Emerg Infect Dis. 7(6):920-926.

[PDF-40.71 KB]

Details:

Alternative Title:

Emerg Infect Dis

Personal Author:

Rosenthal, S. R. ; Merchlinsky, M. ; Kleppinger, C. ; Goldenthal, K. L. ;

Description:

New stockpiles of smallpox vaccine are required as a contingency for protecting civilian and military personnel against deliberate dissemination of smallpox virus by terrorists or unfriendly governments. The smallpox vaccine in the current stockpile consists of a live animal poxvirus (Vaccinia virus [VACV]) that was grown on the skin of calves. Because of potential issues with controlling this earlier manufacturing process, which included scraping VACV lesions from calfskin, new vaccines are being developed and manufactured by using viral propagation on well-characterized cell substrates. We describe, from a regulatory perspective, the various strains of VACV, the adverse events associated with calf lymph-propagated smallpox vaccine, the issues regarding selection and use of cell substrates for vaccine production, and the issues involved in demonstrating evidence of safety and efficacy.

Subject:

[+]

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases

Main Document Checksum:

[+]

Supporting Files:

	11747717.nxml	text/plain
	license.txt	text/plain

No Related Documents.

You May Also Like:

Clinical guidance for smallpox vaccine use in a postevent vaccination program

Personal Author:

Petersen, Brett W.; Damon, Inger K.; Pertowski, Carol A.; Meaney-Delman, Dana; Guarnizo, Julie T.; Beigi, Richard H.; Edwards, Kathryn M.; Fisher, Margaret C.; Frey, Sharon E.; Lynfield, Ruth; Willoughby, Rodney E.;

Corporate Authors:

National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Centers for Disease Control and Prevention (US.). Office of Public Health Preparedness and Response.

Published Date:

February 20, 2015

Series:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 64, no. RR-2

Description:

This report outlines recommendations for the clinical use of the three smallpox vaccines stored in the U.S. Strategic National Stockpile for persons who are exposed to smallpox virus or at high risk for smallpox infection during a postevent vaccinati...

Status:

current

File Type:

[PDF - 672.77 KB]
Recommendation for Using Smallpox Vaccine in a Pre-Event Vaccination Program : recommendations of the Advisory Committee on Immunization Practices (ACIP)

Personal Author:

Wharton, Melinda; Strikas, Raymond A.; Harpaz, Rafael; Rotz, Lisa D.; Schwartz, Benjamin; Casey, Christine G.; Pearson, Michele L.; Anderson, Larry J.;

Corporate Authors:

United States. Advisory Committee on Immunization Practices.. Healthcare Infection Control Practices Advisory Committee (U.S.). National Center for Infectious Diseases (U.S.).

Published Date:

April 4, 2003

Source:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2003; 52(RR-7):1-16.

Description:

This report supplements the 2001 statement by the Advisory Committee on Immunization Practices (ACIP) (CDC. Vaccinia [smallpox] vaccine: recommendations of the Advisory Committee on Immunization Practices [ACIP], 2001. MMWR 2001;50[No. RR-10]:1-25). ...

Status:

current

File Type:

[PDF - 236.60 KB]
Tracking patients and vaccines in large scale events

Corporate Authors:

Association of State and Territorial Health Officials (U.S.). Centers for Disease Control and Prevention (U.S.).

Published Date:

June 2006

Description:

"To protect all Americans during an influenza pandemic, it is estimated that thousands of healthcare providers would need to administer 600 million vaccinations to 300 million patients. Such a campaign would require extensive tracking of patients and...

File Type:

[PDF - 243.07 KB]
Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis : 2005 CDC guidelines

Personal Author:

Tiwari, Tejpratap; Murphy, Trudy V.; Moran, John S.;

Corporate Authors:

National Immunization Program (Centers for Disease Control and Prevention)

Published Date:

December 9, 2005

Series:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 54, no. RR-14

Description:

The recommendations in this report were developed to broaden the spectrum of antimicrobial agents that are available for treatment and postexposure prophylaxis of pertussis. They include updated information on macrolide agents other than erythromycin...

File Type:

[PDF - 672.77 KB]
Personalized Vaccinology: A Review

Personal Author:

Poland, GA; Ovsyannikova, IG; Kennedy, RB;

Published Date:

July 31 2017

Source:

Vaccine. 36(36):5350-5357

Description:

At the current time, the field of vaccinology remains empirical in many respects. Vaccine development, vaccine immunogenicity, and vaccine efficacy have, for the most part, historically been driven by an empiric "isolate-inactivate-inject" paradigm. ...

File Type:

[PDF - 489.42 KB]